Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index

BACKGROUND: Cancer patients are at increased risk for venous thromboembolism (VTE) due to cancer-induced hypercoagulability. However, current guidelines do not routinely recommend prophylactic use of oral anticoagulants to prevent VTE in cancer patients. OBJECTIVE: To evaluate the efficacy and safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yeo Jin, Choi, Yong Won, Chae, Jung-woo, Yun, Hwi-yeol, Shin, Sooyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114826/
https://www.ncbi.nlm.nih.gov/pubmed/33994816
http://dx.doi.org/10.2147/RMHP.S306760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114826/
https://www.ncbi.nlm.nih.gov/pubmed/33994816
http://dx.doi.org/10.2147/RMHP.S306760

Ejemplares similares